Click here to load reader
Upload
pixelate
View
1.035
Download
2
Embed Size (px)
DESCRIPTION
by Celeste A. Rose and Donald E. Mayer, Qual Assur J 2005; 9, 273–282.
Citation preview
DOI: 10.1002/qaj.345
The Regulatory and Business Rolesof a Study Director
Celeste A. Rose1,* and Donald E. Mayer2
1 RoseTECH Consulting, Inc., 1135 Dorothea Drive, Painesville, OH 44077, USA2 Don Mayer Quality Consulting, Inc., 11011 Auburn Road, Chardon, OH 44024, USA
Summary
The role of Study Director can be a challenging one with technical, administrative,and compliance responsibilities. The Study Director often does not have directresponsibility for personnel and other resources required for his/her studies. In thisarticle, we have attempted to identify traits and mechanisms to help the StudyDirector do his/her job in a professional and compliant manner.In addition to regulatory and scientific expertise, Study Director quality attributesinclude possession of appropriate soft skills and character traits and are key to thesuccess of a study. Study Directors must have an aptitude for effective communica-tion, relationship building, training, mentoring, and delegation. While these softskills/desirable traits often require additional effort on the part of the Study Director,they have a large impact on the rate of success, efficiency, and compliance of thestudy overall.The workshop presented by the authors took a ‘hands-on’ approach building onthe creativity, and experience of Study Directors, supervisors, managers, andQuality Assurance (QA) personnel who participated. The participants deliberatedproblem scenarios from a Study Director’s perspective. The tables and discussion inthis article summarize compliant solutions, which arose from the resourcefulnessthat comes from experience of the participants. Copyright # 2005 John Wiley &Sons, Ltd.
Key Words: Study Director; Good Laboratory Practice; GLP; roles and responsibilities; qualityattributes; training
Introduction
In the Good Laboratory Practice (GLP) regula-
tions, the Study Director represents the single
point of study control and has overall respon-
sibility for the scientific and technical conduct of
the study [1–4]. What responsibilities are placed
on the Study Director to maintain this control?
What if the Study Director’s regulatory respon-
sibilities and business authority for aspects of
the study are not aligned?
Study Directors generally do not have busi-
ness control over studies. For example, persons
placed in the role of Study Director may
or may not have control over personnel manage-
ment. They may or may not have control
over, or input in, the selection or assignment of
personnel to specific study or project tasks.
Allocation of equipment and other resources are
usually not within Study Director control.
Management generally determines project prior-
itization and expected completion dates.
*Correspondence to: C. A. Rose, RoseTECH Consulting,Inc., 1135 Dorothea Drive, Painesville, OH 44077, USA.E-mail: [email protected]
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
Yet, the Study Director has the regulatory
responsibilities for the control of the study. So, if
a Study Director has limited control over the
assignment of study and support personnel,
resource allocation, prioritization, timing, bud-
get, and training, what can a Study Director
do to fulfill the obligation to maintain study
control?
The Roles/Responsibilities of the StudyDirector
‘Study Director’ is not a typical industry job
title. An individual is rarely hired for the sole
purpose of being a Study Director. Indivi
duals performing the role of Study Director
generally have many other job functions in
addition to the regulatory responsibilities. The
job functions of a Study Director fall into three
categories: technical, administrative, and com-
pliance.
Technical role
The technical role of the Study Director includes
the scientific responsibilities for the study plan/
protocol design and approval; oversight of data
collection, interpretation, analysis, documenta-
tion, and reporting of results; and the derivation
of study conclusions. In some cases, the indivi-
dual may be the lead scientist responsible for the
coordination of the study with other scientists or
Principal Investigators. Persons functioning in
the role of a Study Director may be responsible
for multiple studies. They may also be involved
in non-regulatory projects or regulatory studies
for which they are not Study Directors. For
example, the individual may be the in-house
veterinarian, or a senior scientist who is the
resident expert in a particular analytical techni-
que such as advanced mass spectrometry.
Business/administrative role
Study Directors undoubtedly have business and
administrative job duties, which consume a
portion of their workday, e.g. supervisory roles
or business development responsibilities. Study
Directors employed by contract research orga-
nizations (CRO) have the added obligation of
conducting the study within a profit margin.
Study Directors at sponsor companies have
the business pressure of overseeing that the
study is cost-effective and meets budgetary
constraints.
Compliance role
Thirdly, the Study Director role includes a
number of GLP compliance responsibilities.
Many of these Study Director responsibilities
are clearly stated in the Food and Drug
Administration’s (FDA) 21 Code of Federal
Regulations (CFR) Part 58 and the Environ-
mental Protection Agency (EPA) 40 CFR Parts
160 and 792 GLP regulations [1–3]. The Study
Director has overall responsibility for the
technical conduct of the study, as well as for
the interpretation, analysis, documentation, and
reporting of results and represents the single
point of study control. The Study Director must
also assure that:
* The protocol and any changes are approved
and followed.* Experimental data, including unanticipated
observations, are accurately recorded and
verified.* Circumstances which may affect study qual-
ity and integrity are properly noted, and
appropriate corrective actions are taken and
documented.* Raw data, documentation, protocols, speci-
mens, and final reports are transferred to the
archives.
The GLP regulations state that it is the
responsibility of the Study Director to assure
that all applicable GLP regulations are followed
[1–4]. Some compliance responsibilities are
therefore inherited by the Study Director. For
example, test and control material characteriza-
tion, which is designated in the regulations as
management responsibilities, may be delega-
ted either intentionally or by default to the
274 CA Rose and DE Mayer
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
Study Director. Training of study personnel may
also fall into the responsibility of the Study
Director.
According to the GLP regulations, the Study
Director is responsible for conduct of the study
and ensuring overall study compliance with the
protocol, standard operating procedures (SOPs),
and the GLP regulations [1–4]. This implies
therefore that in addition to the responsibilities
directly specified in the GLP regulations, the
Study Director is also responsible for compli-
ance issues related to education, experience, and
training of personnel; use, maintenance, calibra-
tion, and qualification of equipment; validation
of computer systems used in the study; existence
and applicability of SOPs; record-keeping prac-
tices and control of study documentation;
handling, storage, and labeling of reagents,
solutions, and mixtures; identification of test
materials and test systems; basically all aspects
of GLP compliance of a study!
Anyone who has ever served in the role of a
Study Director knows that it is indeed a
demanding role. Compounding this burden,
Study Directors frequently have the responsi-
bility for multiple concurrently running regula-
tory studies and many studies today are multi-
site studies as well.
So, how can a Study Director get all this
done? How can a Study Director fulfill all of the
GLP roles and responsibilities as well as the
employer demands and expectations and still do
their job effectively?
Soft Skills and Desirable Traits for theStudy Director
We have all heard the overused adage about
working smarter versus working harder. But
what does that really mean? The obvious come
to mind; skills, training, education, experience.
But all Study Directors have skills, training,
education, and experience (at least they better
according to the GLP regulations!).
In addition to the expected technical skills and
expertise, e.g. animal husbandry, analytical
methodology, equipment operation; other skills
and character traits can make the difference
between a well-executed compliant study and a
study plagued with inherent problems and
compliance issues.
The prototypical Study Director is an effective
communicator with good verbal, written, and
listening communication skills. Relationship
building is also a much-needed skill. It is
through effective communication and strong
relationships that the Study Director can fulfill
regulatory obligations in spite of the lack of
direct business authority.
The Study Director must also be able to
delegate some responsibilities and delegate
wisely. A proficient Study Director determines
which duties are appropriate for delegation and
delegates to study personnel who are competent
in handling the task. An example of such a
responsibility is data verification. On the other
hand, signing of the final report is not a
responsibility that can be delegated in compli-
ance with the GLPs. The ability to recognize
what is important and what is not, and therefore
what can be effectively and safely delegated and
what cannot, is a valuable trait. The skill of
effective delegation is closely related to the
relationship-building characteristic, as trust is a
key part of delegation. Being able to discern
whether or not to trust a delegated task to
someone is very important.
Lastly, the Study Director must be dedicated,
not only to the enormous task of being a Study
Director, but also to the study support team
which has been built to perform and manage the
many facets of a GLP study.
The above traits come about by the same
means with which we acquire all traits; some are
innate, some learned, some developed through
experience and lessons learned. It is important to
be aware of our strengths and weaknesses and
be open to developing and enhancing these
skills, and achieving a balance.
Quality Conduct of Studies
The GLP regulations describe in great detail
the ‘what’ that is required for the execution
The Regulatory and Business Roles of a Study Director 275
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
of a compliant study. Protocol requirements
(58.120), study conduct requirements (58.130),
final report requirements (58.185), and SOP
requirements (58.81), for example, list what
components must be addressed [1]. Specifics on
requirements for labeling, documentation, test
material handling, and characterization are
detailed in the regulations. But the regulations
do not describe the ‘how’ of executing a quality
study.
The following are proactive and positive
strategies, which can be utilized to achieve study
compliance and quality.
Pre-study planning and study initiationmeetings
Pre-study planning and study initiation meetings
can be an effective approach to heading off
unforeseen or undesirable study issues. These
meetings may be focused on a single study or on
common issues relating to similar types of
studies. The Study Director or Principal Inves-
tigator organizes the meeting for study person-
nel to determine specific needs and issues. Items
such as SOPs and study procedures, personnel
and training, and equipment resources are
examples of pre-study planning discussion to-
pics. These discussions often lead to ‘error
prevention’, and result in optimized and updated
SOPs, trained personnel, and resource availabil-
ity. Early identification and correction of study
design flaws may reduce occurrence of pro-
blems. Study deficiencies or potential problems
can be identified and addressed preemptively;
often by protocol or protocol amendments or
other authorized changes.
Effective communication with studypersonnel, management, and qualityassurance
Two-way trust and communication between the
Study Director and the study personnel, man-
agement, and quality assurance (QA) are funda-
mental building blocks for successful study
conduct. Study personnel who are comfortable
approaching the Study Director will be more
likely to report encountered deviations in a
timely manner. They will also be more likely to
seek assistance when they are unsure of a
situation, or provide suggestions for improve-
ment of procedures or systems. Synergy between
the Study Director and QA with a focus on the
study instead of personalities is a major factor in
study compliance and quality. Effective commu-
nication between the Study Director and man-
agement is vital. For example, the Study
Director must be able to freely discuss with
management the regulatory reasons as well as
business justification for requests for increased
resources whether that be equipment or
personnel. The Study Director must also make
a valiant effort to understand and accept
the business decisions, which may result in
denial of requests.
For multi-site studies, Organization for Eco-
nomic Co-operation and Development (OECD)
GLPs permit the Study Director to delegate
defined responsibility to an individual in the
capacity of a Principal Investigator, although the
Study Director’s responsibility for the overall
conduct of the study cannot be delegated [4–6].
The Study Director and Principal Investigator
must communicate on study issues, including
routine and non-routine matters, deviations, and
problems. In the event of serious communication
difficulties between the Study Director and
Principal Investigator, which become irresolva-
ble and/or affect study integrity, test site
management should consider replacement of
the Principal Investigator. Since the study con-
duct remains the Study Director’s responsibility,
determination of the impact of this action on the
study and appropriate remediation, if required,
needs to occur. Clearly, intercepting problems
like this before they become more serious is
preferential. Full understanding of OECD GLPs
is a necessity.
Communication between QA, Study Director,
Principal Investigator, test site personnel, and
test facility management is necessary to identify
and address study issues. Occasionally disagree-
ments and conflicts between these individuals
276 CA Rose and DE Mayer
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
and groups do arise. Disagreements and conflicts
may be a result of a misunderstanding or lack of
training. The best resolution involves getting all
parties to a common ground to work out
contentious issues. This often is a difficult task,
in that either or both sides may carry emotional
baggage, which prevents dealing with real
issues. The issues should be focused objectively
on the study rather than subjectively on the
personalities involved. Examination of the
underlying problems may indicate that potential
issues and problems could have been headed off
before the study initiation. The proactive ap-
proach of pre-study meetings may avert dis-
agreements and conflicts by clarifying
understandings from the start.
The study’s compliance remains the responsi-
bility of the Study Director. The Study Director
must decide responsibly how to deal with
QA audit findings, and many other situations.
QA is in a position to help the Study Director
improve the study. QA’s role in documenting
audit findings and recommendations is to con-
tribute to assuring study compliance. Study
Directors should regard QA input from this
perspective.
When all parties have the best interest of the
study in mind, workable solutions are more
easily derived. Involving supervision or manage-
ment of either or both parties may be needed in
some cases. However, their involvement often
comes without a full understanding of the real
issues.
Training and mentoring
Lack of training, under-qualified personnel, and/
or insufficient procedures have a profoundly
negative impact on a study. The Study Director
must usually involve management, employ
resourceful thinking, and seek the help of other
skilled personnel for resolution of matters,
which are outside the Study Director’s direct
control.
Targeted training and skill building of study
personnel are sound approaches for promoting
understanding and assuring that individuals are
capable of performing job functions. Targeted
training is designed to meet specific identified
training needs, aimed at a specific audience.
Training which is effectively targeted and
delivered leads to the achievement of demon-
strable competency levels. Given the time
pressures around study activities, targeted train-
ing makes effective use of personnel and
resources. The Study Director, supervisor, and
management should confer and determine spe-
cific training needs, and provide that training
prior to or during the study.
On-the-job training provided by qualified
skilled personnel is an effective means of
accomplishing this. It is important that trainees
are presented with timely opportunities to utilize
the newly learned skill in order to reinforce the
training. Based on the degree of difficulty of the
newly learned matter or technique, the extent of
direct oversight and follow-up monitoring
needed to ensure adequate demonstration of
competency should be considered.
Mentoring provides the opportunity for less
experienced individuals to gain practical ‘real
life’ occupational knowledge and know-how.
Positive outcomes of mentoring, training,
and skill building of study personnel benefit
the Study Director by establishing confi-
dence to entrust individuals with delegated
tasks.
Delegation of tasks
In order to meet the regulatory responsibilities
and still manage the workload of day-to-day job
functions and tasks, the Study Director must be
an efficient time manager and have the ability to
effectively delegate, multi-task, prioritize, and
schedule time and resources. A Study Director
cannot directly control each and every aspect of
a study; it is only reasonable that some of the
Study Director’s tasks are delegated. Without
some degree of delegation, the Study Director’s
job would be overwhelming and quality of the
study could be negatively affected. Large studies
and even small studies could be arduous and
time consuming.
The Regulatory and Business Roles of a Study Director 277
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
The Study Director should foster an envir-
onment of cooperation and teamwork to
utilize the delegation option. Good work
habits are required of the Study Director, not
only to do all the tasks, but also to be a
working example to those whose help s/he
utilizes in the delegation of work. The im-
portance of the Study Director’s good work
habits in establishing a team atmosphere and a
level of trust with study personnel cannot be
overstated.
According to GLP the Study Director is
responsible for the accuracy of study data and
its verification or review [1–4]. Delegation of
tasks such as data review and verification to
competent and trusted individuals affords the
Study Director the time for the more critical
study aspects. A reliable process for review
of data should be defined and procedura-
lized. Delegation should be made with consid-
eration of delegate’s experiences and capabil-
ities.
Often, management delegates tasks such as
test article characterization and test mixture
analyses to the Study Director. Study Directors
must be aware of these indirect responsibi-
lities and deal with them in an appropriate
fashion. For example, in the event that a test
article characterization has not been cond-
ucted under GLP or has not been characterized
prior to use in the study, the GLP compliance
statement of the final report must include a
statement of non-compliance (and risk possible
study rejection). When GLP characterization is
required, test facility management must provide
resources for the characterization, whether the
work is done in-house or subcontracted to a
capable GLP lab. Test mixture (homogeneity,
stability, and periodic) analyses are usually
study specific and, like GLP characteri-
zation, the analyses require management-pro-
vided resources.
Reduction of errors and inefficiencies
Errors and inefficiencies can take a manageable
situation and turn it into a nightmare. Planning,
effective communication, training, and mentor-
ing are strategies, which contribute to the
avoidance or minimization of errors. Even a
small error has the potential to critically impact
the integrity of a study. The occurrence of errors,
however, is inevitable. Early detection and
mitigation of errors helps to limit the adverse
effects or impact of the error. The impact of an
error can be exponentially damaging, depending
on the stage at which the error is detected. For
example, a weighing error detected prior to
dosing of an animal causes disruption to the
study but may be easily rectified by documenting
the error and simply re-weighing the animal.
However, if the error goes undetected and the
animal is misdosed, the impact of the error and
the corrective action become increasingly sub-
stantial with time. Utilizing under-qualified
personnel results in errors and omissions that
may remain unnoticed until too late to mean-
ingfully rectify.
Inefficiencies consume personnel resources
and waste valuable time. Under-utilization of
personnel or resources is also wasteful and
may result in employee dissatisfaction and
increased turnover. Imbalance of resources can
result in hasty or inadequate study conduct.
Redundancies can result in over-burdening of
personnel and resources. All of these are
examples of inefficiencies, which could contri-
bute to negative study impacts. The GLP
regulations require a sufficient number of
personnel for the timely and proper conduct of
the study.
Procedural and process improvements
Continuous improvement means diligent atten-
tion to practices used by all study personnel.
SOPs, which are not reflective of current
practices or not suitable for a study, can cause
errors and problems. Revision of procedures and
processes need not, and should not, occur only
at specified review intervals. Reviewing/updat-
ing key SOP(s) prior to use in a study can be
effective preventative or corrective measures.
A proactive approach, making changes when
278 CA Rose and DE Mayer
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
deficiencies are observed, with appropriate
review and authorized revision, is a working
approach that may prevent many deviations
and/or special change needs. This becomes very
important to the Study Director who must
assure that procedures, SOPs, and methods are
appropriate for each study. When appropriate,
study-specific procedures may be written
directly in the protocol or protocol amend-
ment.
After study initiation, the Study Director
may authorize changes from SOPs, provided
such changes are authorized in advance of
their implementation. Any procedural change,
whether in the form of study documentation
or a formal protocol amendment, must be
communicated to appropriate study personnel.
Unanticipated SOP deviations must always be
documented in the study file and approved
by the Study Director. The Study Director
must assess the impact of problems and
errors encountered during the study. The
issue, including any root cause determination
and corrective action, and study impact
should be documented in the study file.
Errors of severe impact must be brought to
attention of management and sponsor as
appropriate.
Study Director Workshop ScenarioResponses
An interactive workshop, which focused on
Study Director GLP roles and responsibilities
was presented by the authors at the Society
of Quality Assurance Midwest Chapter
(MWSQA) 2005 Spring Meeting in Toledo,
Ohio, USA. The audience was comprised of
about 20% Study Directors, 10% supervisors
and management, and the remaining 70% were
QA persons who were willing to put on the
Study Director’s ‘hat’.
The attendees were presented with scenarios
pertaining to training, SOPs, time management,
people, and other issues for which the Study
Director is responsible by GLP but could
encounter problems outside their direct control
or authority. The scenarios were designed to
put real life experience and small group creati-
vity to work.
The results summarize the workshop sce-
nario and the attendees’ responses for posi-
tive/proactive solutions. The number of groups
responding is indicated in the left-hand
column; frequency of group responses is
indicated in parentheses in the right-hand
column. Because the groups acted indepen-
dently, it should be noted that the numbers of
these summarized responses should not be
expected to add up to total responses. Please
note that the responses listed in Tables 1–8
are not the only correct or possible solutions
but represent what the groups came up with
in a short period of time (ten minutes per
scenario). Other possibilities may exist. The
authors do not endorse these solutions by
frequency of occurrence. Sometimes the most
thoughtful solutions are not the most fre-
quent.
References
1 FDA. FDA 21 CFR Part 58, Good Laboratory Practice for
Nonclinical Laboratory Studies, 2005.
2. EPA. EPA (FIFRA) 40 CFR Part 160, Good Laboratory
Practice Standards, 2005.
3. EPA. EPA (TSCA) 40 CFR Part 792, Good Laboratory
Practice Standards, 2005.
4. OECD. OECD Principles on Good Laboratory Practice,
OECD Series on Principles of Good Laboratory
Practice and Compliance Monitoring Number 1
(as revised in 1997). ENV/MC/CHEM(98)17.
5. OECD. Application of OECD Principles of GLP to the
Organisation and Management of Multi-Site Studies,
OECD Series on Principles of Good Laboratory
Practice and Compliance Monitoring Number 13. 25
June 2002, ENV/JM/MONO (2002)9.
6. OECD. The Role and Responsibility of the Study
Director in GLP Studies, OECD Series on Principles of
Good Laboratory Practice and Compliance Monitor-
ing Number 8 (Revised). 15 September 1999, ENV/JM/
MONO (99)24.
The Regulatory and Business Roles of a Study Director 279
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
Table 1. Scenario No. 1
What can a Study Director (SD) do when s/he has nocontrol over the personnel assigned to project andthere are potential or real (lack of) training issues?Key Phrase: Personnel lack sufficient training forstudies assigned.(8 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Involve/inform management of needs andactions required.
(5)
b. Review study needs, decide or prioritizetraining needs and document appropriately.
(5)
c. Hold pre-study meeting with assessment ofskills inventory of study personnel.
(3)
d. Review training records to evaluate trainingneeds.
(3)
e. Use supervisor assistance; supervisors trainstudy personnel prior to study.
(2)
f. SD needs greater involvement if training isstill an issue.
(2)
g. Review SOPs; review SOPs with employee. (2)h. Notify QA of situation. (2)i. Assign training mentor. (1)j. Involve less trained employees in less criticalparts of study.
(1)
k. Delay study start until employees aretrained.
(1)
l. Daily SD review of data and records. (1)
Table 2. Scenario No. 2
What should the Study Director (SD) do when astudy is plagued by errors by apparently under-qualified personnel during a study?Key Phrase: Errors on study by under-qualifiedpersonnel.(5 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Assess impact of deviations and problems onstudy integrity.
(4)
b. Apprise management. (4)c. Assess training needs of the personnel andtrain as needed.
(3)
d. Determine root cause of errors/problems. (3)e. Assure corrective actions anddocumentation.
(3)
f. Determine if errors and problems result frompoor protocol, study design or SOPs.
(3)
g. Notify sponsor and/or management ifproblems severely impact study integrity.
(2)
h. SD needs to closely monitor study and verifydata and training records.
(2)
i. Perform risk assessment on critical data. (1)j. Was QA performing in-life inspections? (1)k. Request additional QA inspections andaudits.
(1)
l. Involve supervisor input and training. (1)
Table 4. Scenario No. 4
How as a busy Study Director (SD) do you fulfillyour responsibilities in the role of SD andstill keep up with day-to-day tasks? These tasksmay be other SD’s requests for you to reviewportions of his/her studies, your assigned SOPreviews/revisions, business development responsi-bilities, and/or supervisory responsibilities.Key Phrase: Managing time for SD duties and otherjob functions.(7 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Prioritize/time management/schedulingtime.
(7)
b. Delegation of duties to qualified personnel. (5)c. Work long hours. (1)d. Flexibility. (1)e. Multi-tasking. (1)f. Track trends related to study performanceissues.
(1)
Table 3. Scenario No. 3
As Study Director (SD), you are responsible for studyconduct, including following SOPs. You observe thatsome of the SOPs for your studies are not reflectiveof current practice or are deficient in a number ofpossible ways. What do you do?Key Phrase: SOPs not reflective of current practice.(7 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Update SOPs before use in the study. (5)b. Incorporate SOP changes (practices to beused for this study)in the protocol or amendments. (5)c. Document deviations during the studywhich have already occurred.
(5)
d. Prepare new SOPs for new concerns orproblems encountered during the study.
(1)
e. SD may approve planned departures/deviations from SOPs.
(1)
f. Determine deviation impact on the study. (1)
Table 2. (continued)
280 CA Rose and DE Mayer
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
Table 5. Scenario No. 5
As the Study Director (SD) of several large toxicologyanimal studies, one of the GLP-mandated functionsis to ‘assure that all experimental data, includingobservations of unanticipated responses of the testsystem are accurately recorded and verified.’ Thelarge amount of data generated in your studies isdaunting. Do you delegate some data verification,and if so, how do you decide what to delegate andwhat do you verify/review yourself?Key Phrase: Delegation of Study Director datareview and verification.(6 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Review can be delegated (some or all). (6)b. Delegate some data verification tosupervisor or to experienced person.
(3)
c. Reliable QC process needs to be defined. (2)d. ‘Critical’ data remains responsibility of SD toreview/verify.
(2)
e. SOP for SD delegation of data verification isneeded.
(1)
f. QA to review data at regularly scheduledintervals.
(1)
Table 6. Scenario No. 6
Your management has graciously delegated toyou, the Study Director (SD), the responsibilityfor characterization of test articles and mixturesused in the study. What are the issues, problems,concerns, and solutions?Key Phrase: Management delegatedcharacterization and analysis of test mixtures (toStudy Director).(7 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. Determine whether characterization hasbeen performed or not.
(5)
b. If not characterized under GLP, this becomesa compliance statement item.
(3)
c. If not GLP characterized, conduct GLPcharacterization before study.
(3)
d. Develop and validate analytical method in-house or subcontract/outsourceGLP characterization. (3)e. Requirements for testing homogeneity andstability of test mixtures acknowledged.
(3)
f. Acute toxicology studies frequently areconducted on non-GLP characterized testarticles;this is included in compliance statement. (1)g. Rejection of certain studies is likely if non-GLP characterized test article is used.
(1)
h. Test facility management is responsible toprovide analytical capabilities or outsourcing.
(1)
i. When outsourcing characterization, assureGLP compliance of the subcontractor.
(1)
j. Include specifics (characterization, analyses,homogeneity, and stability) in protocol.
(1)
Table 7. Scenario No. 7
You are Study Director (SD) of an OECD multi-sitestudy. Lead QA and your test facility management areat SD site. There are several Principal Inves-tigators (PIs; each with their respective test sitemanagement) working on various parts of the study.One of the PIs in not responsive or adequatelycommunicative and important deadlines have slippedor been missed. What can and should you as SD do?Key Phrase: OECD multi-site study, unresponsivePrincipal Investigator.(6 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. SD contact PI and PI management. (4)b. Assess impact of missed deadline asdeviation or on study integrity.
(4)
c. Lead QA reports problems to test facilitymanagement, SD, PI, test site managementand QA. (3)d. Investigate why PI is unresponsive,determine action to be taken and replace ifnecessary.
(3)
e. Contact QA. QA contacts PI and test site QA. (2)f. Was PI site properly qualified to do requiredwork?
(2)
g. Have procedure in place to deal with situation. (1)h. Lead QA to conduct site visit to assure workperformed.
(1)
i. Communicate situation to sponsor. (1)j. Is test site facility aware of OECD GLP multi-site study requirements?
(1)
k. Has distribution from test facility to test sitesincluded all information, communication,and documents needed to do assigned work? (1)
g. Quality training. (1)h. Effective communication. (1)i. Management prioritization. (1)
Table 4. (continued) Table 6. (continued)
The Regulatory and Business Roles of a Study Director 281
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.
Table 8. Scenario No. 8
You believe you are a conscientious, skilled,thorough Study Director (SD). However, youencounter a QA auditor whose inspections oraudit findings and recommendations seem undulyharsh, picky, or unfair. How do you deal withthis situation?Key Phrase: Dealing with difficult QA auditorfindings.(8 groups responding)
Potential solutions (number of groups providing thisor comparable response)
a. SD and QA person meet to come to commonground.
(5)
b. Involve supervisor/management for eitheror both parties.
(4)
c. Is this an auditor training/skill issue? (3)d. SD is ultimately responsible for thecompliance of the study.
(3)
e. Evaluate the communication in the auditfindings.
(2)
f. Tackle known problems before starting thestudy; discuss these with QA.
(2)
g. If SD does not deal with compliance issue,get management support for studyquality/integrity/compliance issues. (1)
282 CA Rose and DE Mayer
Copyright r 2005 John Wiley & Sons, Ltd. Qual Assur J 2005; 9, 273–282.